CHIT1 and myeloid sarcoma: Chitotriosidase-1 (CHIT1), a glycosyl hydrolase secreted predominantly by activated microglia, has emerged as a robust biomarker candidate for predicting neurodegeneration in multiple sclerosis (MS).